Brugada syndrome: Epidemiology, risk stratification and clinical management;La sindrome di Brugada: Epidemiologia, stratificazione del rischio e management clinico

Italian Heart Journal Supplement

Volumn 3, Issue 9, 2002, Pages 919-927

  Grillo, Massimiliano ^a   Napolitano, Carlo ^a   Bloise, Raffaella ^a   Priori, Silvia G ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Arrhythmias; Cardiac arrest; Implantable cardioverter defibrillator

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE;

ARRHYTHMOGENESIS; BRUGADA SYNDROME; CARDIOVERSION; DEFIBRILLATOR; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; HEART FIBRILLATION; HIGH RISK PATIENT; HUMAN; LONG QT SYNDROME; REVIEW; SUDDEN DEATH; SYNCOPE; HEART ARREST; HEART ARRHYTHMIA; PHENOTYPE; RISK ASSESSMENT; SYNDROME;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HEART ARREST; HUMANS; PHENOTYPE; RISK ASSESSMENT; SYNCOPE; SYNDROME;

EID: 0242362295     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Osher HL, Wolff L. Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci 1953; 226: 541-5.
2. Martini B, Nava A, Thiene G, et al. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989; 118: 1203-9.
3. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-6.
4. Antzelevitch C. The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J 2001; 22: 356-63.
5. Remme CA, Wever EF, Wilde AA, Derksen R, Hauer RN. Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J 2001; 22: 400-9.
6. Priori SG, Napolitano C, Grillo M. Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res 2001; 50: 218-23.
7. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-6.
8. Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet 2000; 355: 808-9.
9. Suzuki H, Torigoe K, Numata O, Yazaki S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1277-80.
10. Douard H, Sagardiluz J, Chevalier L, Labbe L, Broustet JP. Fortuitous discovery of Brugada syndrome in an asymptomatic 70-year-old sportsman. Ann Cardiol Angeiol 1996; 45: 577-80.
11. Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11: 337-45.
12. Alshinawi C, Mannens M, Wilde A. Mutations in the human cardiac sodium channel gene (SCN5A) in patients with Brugada's syndrome. (abstr) Eur Heart J 1998; 98 (Suppl): 78.
13. Rook MB, Alshinawi C, Groenewegen WA, et al. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 1999; 44: 507-17.
14. Wang Q, Shen J, Splaswki I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805-11.
15. + channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999; 85: 1206-13.
16. Naccarelli GV, Antzelevitch C. The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities. Am J Med 2001; 110: 573-81.
17. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-6.
18. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12: 268-72.
19. Leenherdt A, Glaser E, Burguera M, Nurnberg M, Maison-Blanche P, Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994; 89: 206-15.
20. Viskin S, Lesh MD, Eldar M, et al. Mode of onset of malignant ventricular arrhythmias idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 1997; 8: 1115-20.
21. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36: 1646-53.
22. Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277-85.
23. Corrado D, Nava A, Buja G, et al. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996; 27: 443-8.
24. Martini B, Nava A, Cannas S, Bauce B, Muriago M. La sindrome "morte improvvisa giovanile, blocco di branca destra e sopraslivellamento del tratto ST". Giornale Italiano di Aritmologia e Cardiostimolazione 1999; 2: 7-11.
25. Takagi M, Aihara N, Kuribayashi S, et al. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J 2001; 22: 1032-41.
26. Alings M, Wilde A. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-73.
27. Gussak I, Bjerregaard P, Hammill SC. Clinical diagnosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol 2001; 37: 1635-8.
28. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002; 105: 1342-7.
29. Miyanuma H, Sakurai M, Odaka H, et al. Two cases of idiopathic ventricular fibrillation with interesting electrocardiographic findings. Kokyu To Junkan 1993; 41: 287-91.
30. Nakamura M, Isobe M, Imamura H. Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int J Cardiol 1998; 64: 205-6.
31. Matsuo K, Kurita M, Inagaki M, et al. Circadian patterns of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20: 465-70.
32. Van Den Berg MP, Wilde AA, Viersma JW, et al. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 2001; 12: 630-6.
33. Eckardt L, Kirchhof P, Loh P, et al. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol 2001; 12: 680-5.
34. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa SO. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-70.
35. Nomura M, Nada T, Endo J, et al. Brugada syndrome associated with an autonomic disorder. Heart 1998; 80: 194-6.
36. Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998; 9: 508-12.
37. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999; 85: 803-9.
38. Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000; 11: 396-404.
39. 3 at higher intercostal spaces to detect Brugada syndrome. (abstr) Circulation 2000; 102: 677.
40. 3 and sudden death - the Brugada syndrome. Europace 1999; 1: 156-66.
41. 3 and sudden death. Eur Heart J 2000; 21: 321-6.
42. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000; 102: 2509-15.
43. Priori SG, Napolitano C, Schwartz PJ, Bloise R, Crotti L, Ronchetti E. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2000; 102: 945-7.
44. Goethals P, Debruyne P, Saffarian M. Drug-induced Brugada syndrome. Acta Cardiol 1998; 53: 157-60.
45. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994; 71: 215-8.
46. Zeppilli P. The athlete's heart: differentiation of training effects from organic heart disease. Pract Cardiol 1988; 10: 14-61.
47. Antzelevitch C. The Brugada syndrome. J Cardiovasc Electrophysiol 1998; 9: 513-6.
48. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10: 1301-12.
49. Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374-450.
50. Takenaka S, Kusano KF, Hisamatsu K, et al. Relatively benign clinical course in asymptomatic patients with Brugada-type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol 2001; 12: 2-6.
51. Brugada J, Brugada R, Brugada P. Asymptomatic patients with a Brugada electrocardiogram: are they at risk? J Cardiovasc Electrophysiol 2001; 12: 7-8.
52. Atarashi H, Ogawa S, Harumi K, et al, for the Idiopathic Ventricular Fibrillation Investigators. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. J Am Coll Cardiol 2001; 37: 1916-20.
53. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001; 37: 1628-34.
54. 3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97: 457-60.
55. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001; 12: 1004-7.
56. Priori SG. Foretelling the future in Brugada syndrome: do we have the crystal ball? J Cardiovasc Electrophysiol 2001; 12: 1008-9.